Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Edurant / Truvada

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gilead cracks down on HIV fraud with new motion
    Gilead cracks down on HIV fraud with new motion

    21 Apr 2022

    // A. Keown BIOSPACE

    https://www.biospace.com/article/gilead-sciences-fights-back-against-hiv-drug-fraud/

    A. Keown BIOSPACE
    21 Apr 2022
    Share Share
    Gilead’s converting Truvada PrEP users to Descovy faster than expected
    Gilead’s converting Truvada PrEP users to Descovy faster than expected

    03 Dec 2019

    // Angus Liu  FIERCE PHARMA

    https://www.fiercepharma.com/marketing/gilead-s-converting-truvada-prep-users-to-descovy-faster-than-expected-analyst

    Angus Liu  FIERCE PHARMA
    03 Dec 2019
    Share Share
    Who Owns H.I.V.-Prevention Drugs? The Taxpayers, U.S. Says
    Who Owns H.I.V.-Prevention Drugs? The Taxpayers, U.S. Says

    08 Nov 2019

    // D. G. McNeil NY TIMES

    https://www.nytimes.com/2019/11/08/health/hiv-prevention-truvada-patents.html

    D. G. McNeil NY TIMES
    08 Nov 2019
    Share Share
    Gilead elevates M&A architect Dickinson to CFO. Could more deals be next?
    Gilead elevates M&A architect Dickinson to CFO. Could more deals be next?

    16 Oct 2019

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/gilead-elevates-m-a-architect-dickinson-to-cfo-could-more-deals-be-next

    Angus Liu FIERCE PHARMA
    16 Oct 2019
    Share Share
    AbbVie, Gilead and Allergan 3-peat with September's top pharma TV spending
    AbbVie, Gilead and Allergan 3-peat with September's top pharma TV spending

    15 Oct 2019

    // Beth Snyder Bulik FIERCE PHARMA

    https://www.fiercepharma.com/marketing/abbvie-gilead-and-allergan-three-peat-top-pharma-tv-spending-for-september-2019-tv

    Beth Snyder Bulik FIERCE PHARMA
    15 Oct 2019
    Share Share
    U.S. Reps question Gilead's donation of free HIV drug Truvada
    U.S. Reps question Gilead's donation of free HIV drug Truvada

    27 Jun 2019

    // Arlene Weintraub FIERCE PHARMA

    https://www.fiercepharma.com/pharma/us-reps-to-gilead-did-your-donation-free-hiv-prevention-drug-truvada-have-strings-attached

    Arlene Weintraub FIERCE PHARMA
    27 Jun 2019
    Share Share